These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 14665375

  • 1. Lipid peroxidation and its correlations with urinary levels of oxalate, citric acid, and osteopontin in patients with renal calcium oxalate stones.
    Huang HS, Ma MC, Chen CF, Chen J.
    Urology; 2003 Dec; 62(6):1123-8. PubMed ID: 14665375
    [Abstract] [Full Text] [Related]

  • 2. Erythrocyte oxidative stress in patients with calcium oxalate stones correlates with stone size and renal tubular damage.
    Ma MC, Chen YS, Huang HS.
    Urology; 2014 Feb; 83(2):510.e9-17. PubMed ID: 24360074
    [Abstract] [Full Text] [Related]

  • 3. 24-Hour Urinary Chemistries and Kidney Stone Risk.
    Ferraro PM, Taylor EN, Curhan GC.
    Am J Kidney Dis; 2024 Aug; 84(2):164-169. PubMed ID: 38583757
    [Abstract] [Full Text] [Related]

  • 4. N-acetyl-beta-D-glucosaminidase excretion in healthy children and in pediatric patients with urolithiasis.
    Balla AA, Salah AM, Abdalmotaal E, Hoppe B, Bongartz D, Kessler T, Hesse A.
    World J Urol; 1998 Aug; 16(6):413-6. PubMed ID: 9870291
    [Abstract] [Full Text] [Related]

  • 5. Renal tubular cell damage and oxidative stress in renal stone patients and the effect of potassium citrate treatment.
    Tungsanga K, Sriboonlue P, Futrakul P, Yachantha C, Tosukhowong P.
    Urol Res; 2005 Feb; 33(1):65-9. PubMed ID: 15565439
    [Abstract] [Full Text] [Related]

  • 6. Lipid peroxidation is not the underlying cause of renal injury in hyperoxaluric rats.
    Green ML, Freel RW, Hatch M.
    Kidney Int; 2005 Dec; 68(6):2629-38. PubMed ID: 16316339
    [Abstract] [Full Text] [Related]

  • 7. Metabolic Profile of Calcium Oxalate Stone Patients with Enteric Hyperoxaluria and Impact of Dietary Intervention.
    Siener R, Ernsten C, Welchowski T, Hesse A.
    Nutrients; 2024 Aug 13; 16(16):. PubMed ID: 39203825
    [Abstract] [Full Text] [Related]

  • 8. Early changes of oxalate and calcium urine excretion in those with calcium oxalate stone formation after extracorporeal shock wave lithotripsy.
    Oehlschläger S, Albrecht S, Hakenberg OW, Schrödter S, Froehner M, Manseck A, Wirth MP.
    Urology; 2003 Jul 13; 62(1):17-21. PubMed ID: 12837412
    [Abstract] [Full Text] [Related]

  • 9. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D, Strazzullo P, Lotti T, Bianchi G, Borghi L, Caione P, Carini M, Caudarella R, Ferraro M, Gambaro G, Gelosa M, Guttilla A, Illiano E, Martino M, Meschi T, Messa P, Miano R, Napodano G, Nouvenne A, Rendina D, Rocco F, Rosa M, Sanseverino R, Salerno A, Spatafora S, Tasca A, Ticinesi A, Travaglini F, Trinchieri A, Vespasiani G, Zattoni F, CLU Working Group.
    Arch Ital Urol Androl; 2015 Jul 07; 87(2):105-20. PubMed ID: 26150027
    [Abstract] [Full Text] [Related]

  • 10. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO, Schmiedl A, Manoharan M.
    Clin Chem Lab Med; 2004 Mar 07; 42(3):283-93. PubMed ID: 15080561
    [Abstract] [Full Text] [Related]

  • 11. Reduction of urinary oxalate by combined calcium and citrate administration without increase in urinary calcium oxalate stone formers.
    Ito H, Suzuki F, Yamaguchi K, Nishikawa Y, Kotake T.
    Clin Nephrol; 1992 Jan 07; 37(1):14-8. PubMed ID: 1541059
    [Abstract] [Full Text] [Related]

  • 12. Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers.
    Otto BJ, Bozorgmehri S, Kuo J, Canales M, Bird VG, Canales B.
    J Endourol; 2017 Dec 07; 31(12):1335-1341. PubMed ID: 29084490
    [Abstract] [Full Text] [Related]

  • 13. Nephrolithiasis: a consequence of renal epithelial cell exposure to oxalate and calcium oxalate crystals.
    Khan SR, Thamilselvan S.
    Mol Urol; 2000 Dec 07; 4(4):305-12. PubMed ID: 11156696
    [Abstract] [Full Text] [Related]

  • 14. Urinary citrate excretion in patients with renal calculi.
    Menon M, Mahle CJ.
    J Urol; 1983 Jun 07; 129(6):1158-60. PubMed ID: 6854790
    [Abstract] [Full Text] [Related]

  • 15. Low urinary citrate excretion in nephrolithiasis.
    Nicar MJ, Skurla C, Sakhaee K, Pak CY.
    Urology; 1983 Jan 07; 21(1):8-14. PubMed ID: 6823713
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status.
    Thamilselvan S, Menon M.
    BJU Int; 2005 Jul 07; 96(1):117-26. PubMed ID: 15963133
    [Abstract] [Full Text] [Related]

  • 19. Calcium oxalate stone disease: role of lipid peroxidation and antioxidants.
    Selvam R.
    Urol Res; 2002 Mar 07; 30(1):35-47. PubMed ID: 11942324
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.